Undeterred by a definitive clinical-trial failure, Medtronic said it will continue to develop its medical device for high blood pressure in hopes of winning U.S. regulatory approval.
from WSJ.com: US Business http://ift.tt/1lu8zQf
via IFTTT
from WSJ.com: US Business http://ift.tt/1lu8zQf
via IFTTT
No comments:
Post a Comment